Challenges in Classifying Adverse Events in Cancer Clinical Trials Steven Joffe, MD, MPH Dave Harrington, PhD David Studdert, JD, PhD Saul Weingart, MD,
Challenges in Classifying Adverse Events in Cancer Clinical Trials
